Anixa Biosciences (ANIX) Revenue (2010 - 2023)
Anixa Biosciences' (ANIX) quarterly Revenue came in at $210000.0 in Q2 2023, up 21100.0% quarter-over-quarter from -$1000.0 in Q4 2021.
Powered by 
Analysis
Anixa Biosciences (ANIX) Revenue (2010 - 2023) Analysis & Trends
Anixa Biosciences (ANIX) has reported Revenue for 11 consecutive years, with $210000.0 the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Revenue changed N/A year-over-year to $210000.0; the trailing twelve-month figure through Oct 2023 stood at $209000.0 (changed N/A YoY), and the FY2023 full-year result was $210000.0, changed N/A from the prior year.
- Revenue climbed to $210000.0 in Q2 2023 per ANIX's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Revenue topped out at $513000.0 in Q1 2021 and bottomed at -$1000.0 in Q4 2021.
- Historically, Revenue has averaged $243000.0 across 3 years, with a median of $230000.0 in 2019.
- The widest YoY moves for Revenue: up 66.67% in 2019, down 66.67% in 2019.
- Over 3 years, Revenue stood at $250000.0 in 2019, then slumped by 100.4% to -$1000.0 in 2021, then jumped by 21100.0% to $210000.0 in 2023.
- According to Business Quant data, Revenue over the past three periods registered $210000.0, -$1000.0, and $513000.0 for Q2 2023, Q4 2021, and Q1 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.25 Bn | 9.40 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.58 Bn | 2.62 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 490,000.00 |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 77.46 Mn |
| 10 | Anixa Biosciences | 91.91 Mn | 91.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2023 | 210,000.00 |
| Oct 31, 2021 | -1,000.00 |
| Jan 31, 2021 | 513,000.00 |
| Apr 30, 2019 | 250,000.00 |
| Jul 31, 2018 | 362,500.00 |
| Apr 30, 2018 | 750,000.00 |
| Jul 31, 2017 | 362,500.00 |
| Oct 31, 2016 | 200,000.00 |
| Jul 31, 2016 | 100,000.00 |
| Jul 31, 2015 | 95,000.00 |
| Apr 30, 2015 | 25,000.00 |
| Jan 31, 2015 | 9.14 Mn |
| Oct 31, 2014 | 1.38 Mn |
| Jul 31, 2014 | 1.19 Mn |
| Oct 31, 2012 | 350.00 |
| Jul 31, 2012 | 249,470.00 |
| Apr 30, 2012 | 248,070.00 |
| Jan 31, 2012 | 449,195.00 |
| Oct 31, 2011 | 448,960.00 |
| Jul 31, 2011 | 450,360.00 |